Strs Ohio Immuno Gen, Inc. Transaction History

Strs Ohio

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	BUY	$12.46 - $29.95 $224,280 - $539,100	18,000 Added 62.07%	47,000 $1.39 Million
Q3 2023 Oct 26, 2023	SELL	$14.09 - $19.87 $670,684 - $945,812	-47,600 Reduced 62.14%	29,000 $460,000
Q2 2023 Jul 31, 2023	SELL	$3.75 - $20.05 $29,250 - $156,390	-7,800 Reduced 9.24%	76,600 $1.45 Million
Q1 2023 Aug 02, 2023	BUY	$3.67 - $4.92 $28,626 - $38,376	7,800 Added 10.18%	84,400 $324,000
Q4 2022 Jan 26, 2023	SELL	$4.55 - $6.31 $216,580 - $300,356	-47,600 Reduced 36.06%	84,400 $418,000
Q2 2022 Jul 25, 2022	BUY	$3.15 - $5.76 $12,600 - $23,040	4,000 Added 3.13%	132,000 $594,000
Q4 2021 Jan 24, 2022	BUY	$4.75 - $7.5 $19,475 - $30,750	4,100 Added 3.31%	128,000 $949,000
Q3 2021 Oct 22, 2021	SELL	$5.02 - $6.59 $25,601 - $33,609	-5,100 Reduced 3.95%	123,900 $702,000
Q2 2021 Jul 26, 2021	BUY	$5.79 - $8.6 $746,910 - $1.11 Million	129,000 New	129,000 $850,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.